变量,类型,阴性组(n=25),阳性组(n=63),P值
预防措施_药物预防+机械预防,分类,18/25 (72.0%),4/63 (6.3%),8.190255744827127e-10
机械预防措施（VTE确诊前）_气压治疗,分类,22/25 (88.0%),10/63 (15.9%),1.0771284346088353e-09
机械预防措施（VTE确诊前）_0,分类,3/25 (12.0%),53/63 (84.1%),1.0771284346088353e-09
是否机械预防,分类,22/25 (88.0%),11/63 (17.5%),3.2179608869767673e-09
首次VTE中高风险评分日期与机械预防日期差值_无,分类,3/25 (12.0%),48/63 (76.2%),1.4258379435906118e-07
VTE首次中高危评分日期与机械预防日期差值_none,分类,3/25 (12.0%),48/63 (76.2%),1.4258379435906118e-07
VTE诊断日期与入院日期是否大于24h,分类,24/25 (96.0%),25/63 (39.7%),5.1581236047879705e-06
规范预防,分类,16/25 (64.0%),9/63 (14.3%),1.0748241814556466e-05
VTE确诊日期与入院日期差值,连续,9.04±5.94,2.95±6.17,1.1166219955761935e-05
预防措施_无预防,分类,0/25 (0.0%),21/63 (33.3%),0.002436711792722991
预防措施_药物预防,分类,3/25 (12.0%),31/63 (49.2%),0.0027902261768724657
中性粒细胞绝对值(NEUT#)（*10^9/L）,连续,8.09±3.76,6.11±3.70,0.003099191604622025
是否步速缓慢,分类,23/25 (92.0%),36/63 (57.1%),0.0039041027028246978
白细胞计数(*10^9/L),连续,10.14±3.92,8.15±3.59,0.006031718177828178
住院天数,连续,20.12±10.26,13.10±11.13,0.006652747369477233
我院相关VTE,分类,24/25 (96.0%),42/63 (66.7%),0.009515678813898533
总钙(mmol/L),连续,2.09±0.12,2.17±0.13,0.011409678539433168
本次入院前90天有无住院史、治疗史、手术史,分类,11/25 (44.0%),47/63 (74.6%),0.013064986060631513
VTE评估量表（padua1，caprini2，P+C3）_padua,分类,8/25 (32.0%),40/63 (63.5%),0.014756123281609761
是否体力活动水平低,分类,21/25 (84.0%),34/63 (54.0%),0.017301549534770495
是否药物预防,分类,21/25 (84.0%),35/63 (55.6%),0.02407898511324712
纤维蛋白原Fbg（g/L）,连续,4.34±1.35,3.77±1.00,0.029779403077492578
VTE评估量表（padua1，caprini2，P+C3）_caprini,分类,15/25 (60.0%),21/63 (33.3%),0.03995942512921725
是否久坐/卧床,分类,19/25 (76.0%),31/63 (49.2%),0.0403818470537704
90天前是否我院就诊,分类,5/25 (20.0%),29/63 (46.0%),0.043482636550600404
嗜酸性粒细胞比值,连续,1.43±1.68,2.20±2.12,0.05358877184482126
VTE中高危评分,连续,7.60±3.01,6.30±2.75,0.06273303864266738
首次DD与入院日期差值与VTE首次中高危评分日期差值,连续,0.96±2.19,-0.33±2.24,0.0655381581178466
医院相关性VTE,分类,5/25 (20.0%),27/63 (42.9%),0.0776495615370554
首次异常D-二聚体检测数值（μg/ml FEU）_0.56,分类,2/25 (8.0%),17/63 (27.0%),0.0959696298351813
入院科室_康复科,分类,0/25 (0.0%),9/63 (14.3%),0.10859972639794187
活化凝血酶原时间APTT,连续,31.21±5.42,29.20±4.76,0.11333890160084616
VTE首次中高危评分日期与机械预防日期差值_2,分类,2/25 (8.0%),0/63 (0.0%),0.13942941134228187
入院科室_妇科,分类,2/25 (8.0%),0/63 (0.0%),0.13942941134228187
入院科室_脊柱外科,分类,2/25 (8.0%),0/63 (0.0%),0.13942941134228187
VTE首次中高危评分日期与药物预防日期差值_10,分类,2/25 (8.0%),0/63 (0.0%),0.13942941134228187
VTE首次中高危评分日期与药物预防日期差值_16,分类,2/25 (8.0%),0/63 (0.0%),0.13942941134228187
嗜酸粒细胞绝对值(E0#)（*10^9/L）,连续,0.12±0.15,0.15±0.14,0.14268551009541033
VTE首次中高危评分日期与药物预防日期差值_none,分类,7/25 (28.0%),30/63 (47.6%),0.14930638218585562
入院科室_神经外科,分类,6/25 (24.0%),6/63 (9.5%),0.1498120854493017
Braden量表,连续,17.24±4.42,18.65±4.02,0.16066206903773517
钾离子,连续,3.81±0.57,4.00±0.53,0.16110627154816481
VTE首次中高危评分日期与机械预防日期差值_0,分类,8/25 (32.0%),10/63 (15.9%),0.16198944245067468
红细胞计数(*10^12/L),连续,3.61±0.57,3.86±0.75,0.16485294850048504
VTE首次中高危评分日期与入院日期差值,分类,16/25 (64.0%),22/63 (34.9%),0.18225354111420325
入院科室_泌尿外科,分类,4/25 (16.0%),3/63 (4.8%),0.18674649780724734
出血风险评估（1/0）,分类,19/25 (76.0%),37/63 (58.7%),0.20297800006183855
血红蛋白浓度HGB【确诊前最近一次】(g/L),连续,103.84±21.53,108.51±20.51,0.2392962782916338
VTE首次中高危评分日期与机械预防日期差值_1,分类,3/25 (12.0%),2/63 (3.2%),0.2703303797041869
是否疲惫,分类,17/25 (68.0%),33/63 (52.4%),0.27333824273281904
入院收缩压,连续,132.44±27.07,127.52±19.21,0.321875559623262
BMI,连续,22.36±4.19,23.27±3.19,0.3372823551769448
凝血酶原时间PT（s）,连续,12.87±1.64,12.46±1.51,0.35809087772746706
首次异常DD与入院日期差值,分类,23/25 (92.0%),63/63 (100.0%),0.39649539166267844
VTE首次中高危评分日期与机械预防日期差值_-1,分类,2/25 (8.0%),1/63 (1.6%),0.3988177681362911
VTE首次中高危评分日期与药物预防日期差值_-1,分类,2/25 (8.0%),1/63 (1.6%),0.3988177681362911
入院科室_重症医学科,分类,2/25 (8.0%),1/63 (1.6%),0.3988177681362911
首次VTE中高风险评分日期与药物预防日期差值,连续,2.20±4.64,0.48±2.66,0.44491572815056446
是否存在抗凝禁忌,分类,11/25 (44.0%),35/63 (55.6%),0.4580121005636216
VTE首次中高危评分日期与药物预防日期差值_3,分类,0/25 (0.0%),4/63 (6.3%),0.47021040747471765
身高,连续,1.62±0.07,1.63±0.07,0.48004223992301687
首次DD与入院日期差值,分类,18/25 (72.0%),34/63 (54.0%),0.5225293969024372
糖尿病史,分类,6/25 (24.0%),21/63 (33.3%),0.5485612637138149
首次D-二聚体检测数值（μg/ml FEU）,连续,3.23±3.41,2.22±1.73,0.5565357522330394
VTE首次中高危评分日期与药物预防日期差值_0,分类,4/25 (16.0%),15/63 (23.8%),0.6060393426228485
呼吸系统疾病/COPD,分类,16/25 (64.0%),35/63 (55.6%),0.6281803788361566
VTE首次中高危评分日期与药物预防日期差值_14,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与药物预防日期差值_6,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与机械预防日期差值_-6,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与机械预防日期差值_-2,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_0.55,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_0.69,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_0.58,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_0.59,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_0.91,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与机械预防日期差值_-12,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与机械预防日期差值_10,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与机械预防日期差值_28,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与机械预防日期差值_-4,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与机械预防日期差值_8,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_25.44,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_69.25,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_6.74,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_5.86,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_4.98,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_4.66,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_4.18,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_卵巢黏液性囊腺瘤(右侧),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_4.49,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_左侧股骨颈骨折,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_＞20.00,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_3.29,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_10.34,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_10.42,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_12.55,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_2.67,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_1.39,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
首次异常D-二聚体检测数值（μg/ml FEU）_1.71,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_肾恶性肿瘤,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_股骨颈骨折(右侧),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_蛛网膜下腔出血,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_泌尿外科,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_重症肺炎,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_肾肿物(右),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_肾结石(双侧、右侧为著),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_急性肺栓塞,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与药物预防日期差值_-2,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_颞叶出血(左侧）,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_颅内动脉瘤破裂伴蛛网膜下腔出血,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
VTE首次中高危评分日期与药物预防日期差值_2,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_胸椎骨折,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_肾错构瘤破裂出血(左侧),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_脑干出血,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_腰椎间盘突出伴神经根病,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_慢性心力衰竭急性发作,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_急性非ST段抬高型心肌梗死,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_急性脑梗死,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_慢性阻塞性肺病伴急性下呼吸道感染,分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_基底节出血(右侧),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_基底节出血(左侧),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_多发性大脑挫裂伤(双侧额叶、颞叶),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
主要疾病诊断_子宫颈鳞状细胞癌(IB1期),分类,1/25 (4.0%),0/63 (0.0%),0.6301621721848464
入院科室_介入科,分类,0/25 (0.0%),3/63 (4.8%),0.6463252504037398
入院科室_普外科,分类,0/25 (0.0%),3/63 (4.8%),0.6463252504037398
入院科室_血液内科,分类,0/25 (0.0%),3/63 (4.8%),0.6463252504037398
入院科室_肾内科,分类,0/25 (0.0%),3/63 (4.8%),0.6463252504037398
主要疾病诊断_脑出血恢复期,分类,0/25 (0.0%),3/63 (4.8%),0.6463252504037398
年龄,连续,64.84±12.64,62.81±15.90,0.6534349181945983
首次VTE中高风险评分日期与机械预防日期差值,连续,1.08±6.87,0.17±0.93,0.6619739931160262
入院科室_骨关节科,分类,2/25 (8.0%),2/63 (3.2%),0.6798633779366721
手术史,分类,15/25 (60.0%),33/63 (52.4%),0.6818196744148864
感染史,分类,20/25 (80.0%),46/63 (73.0%),0.682236562435615
出院收缩压,连续,125.20±16.11,126.21±18.11,0.704012239081586
性别_女,分类,12/25 (48.0%),26/63 (41.3%),0.736709407334273
性别_男,分类,13/25 (52.0%),37/63 (58.7%),0.736709407334273
预防措施_机械预防,分类,4/25 (16.0%),7/63 (11.1%),0.7886810315522829
高血压史,分类,18/25 (72.0%),42/63 (66.7%),0.8175648711158829
肾功能不全,分类,7/25 (28.0%),21/63 (33.3%),0.8175648711158829
RBC平均血红蛋白浓度(MCHC),连续,327.24±17.62,327.86±14.68,0.8675551861058405
RBC平均血红蛋白量(MCH),连续,28.70±2.77,28.48±2.89,0.8821105698057639
出院舒张压,连续,76.60±11.11,76.02±10.01,0.9115176311396578
主要疾病诊断_肺恶性肿瘤,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
主要疾病诊断_脑梗死恢复期,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
主要疾病诊断_脑梗死亚急性期,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
入院科室_急诊科,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
入院科室_心胸外科,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
入院科室_全科医学科,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
首次异常D-二聚体检测数值（μg/ml FEU）_1.02,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
VTE首次中高危评分日期与药物预防日期差值_4,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
主要疾病诊断_慢性阻塞性肺病伴有急性下呼吸道感染,分类,0/25 (0.0%),2/63 (3.2%),0.913884299300537
入院舒张压,连续,77.84±15.71,77.22±11.26,0.9852211447932777
炎症,分类,19/25 (76.0%),46/63 (73.0%),0.9853675371241557
首次异常D-二聚体检测数值（μg/ml FEU）_1.11,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.1,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.36,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.27,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.25,分类,1/25 (4.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.01,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.72,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.88,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.04,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.79,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.02,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.06,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.12,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.24,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.54,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.81,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.77,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.72,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.98,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.9,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_0.83,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与机械预防日期差值_4,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE评估量表（padua1，caprini2，P+C3）_caprini、padua,分类,1/25 (4.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与机械预防日期差值_6,分类,0/25 (0.0%),1/63 (1.6%),1.0
入院科室_内分泌科,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_11,分类,1/25 (4.0%),1/63 (1.6%),1.0
入院科室_肿瘤科,分类,1/25 (4.0%),2/63 (3.2%),1.0
入院科室_风湿免疫科,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.61,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE评估量表（padua1，caprini2，P+C3）_padua、caprini,分类,1/25 (4.0%),1/63 (1.6%),1.0
入院科室_呼吸与危重症医学科,分类,3/25 (12.0%),8/63 (12.7%),1.0
入院科室_甲乳血管外科,分类,0/25 (0.0%),1/63 (1.6%),1.0
入院科室_吸与危重症医学科,分类,0/25 (0.0%),1/63 (1.6%),1.0
入院科室_创伤骨科,分类,1/25 (4.0%),1/63 (1.6%),1.0
入院科室_神经内科,分类,1/25 (4.0%),2/63 (3.2%),1.0
入院科室_老年医学科,分类,0/25 (0.0%),1/63 (1.6%),1.0
入院科室_甲乳外科,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_29,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_8,分类,1/25 (4.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_9,分类,0/25 (0.0%),1/63 (1.6%),1.0
入院科室_消化内科,分类,0/25 (0.0%),1/63 (1.6%),1.0
入院科室_心血管内科,分类,1/25 (4.0%),4/63 (6.3%),1.0
主要疾病诊断_尿毒症性脑病,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_左腕关节腱鞘囊肿,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_16.9,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_.双侧亚急性硬膜下血肿,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_下肢静脉血栓,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_下肢静脉曲张伴静脉炎( 左),分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_2型糖尿病足,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_2型糖尿病性下肢感染,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_下肢静脉闭塞(右髂静脉),分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_不稳定型心绞痛,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_乳腺恶性肿瘤,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_低钾血症,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.4,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_4.77,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_化疗后骨髓抑制,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_动静脉内瘘狭窄(左上肢) 慢性肾脏病V期 慢性肾脏病贫血 慢性心力衰竭 肾性高血压 继发性甲状旁腺功能亢进 高磷血症 低钙血症,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_7.58,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_6.38,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_5.97,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_5.45,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_6.12,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.02,分类,1/25 (4.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.04,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_3.54,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.55,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.74,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.97,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.48,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.27,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.28,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.38,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_2.13,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.45,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.5,分类,0/25 (0.0%),1/63 (1.6%),1.0
首次异常D-二聚体检测数值（μg/ml FEU）_1.64,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_急性暴发性心肌炎,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_急性消化道穿孔,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_急性阑尾炎，急性胃肠炎,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_急性脑梗死？,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_急性脑梗死（左侧大脑半球）,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_急性心力衰竭,分类,1/25 (4.0%),1/63 (1.6%),1.0
主要疾病诊断_肾输尿管结石伴肾积水和感染,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_急性消化道出血：消化性溃疡并出血？,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_右乳导管乳头状原位癌（pTisN0M0 0期）,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_双肺肺炎,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_发热(社区获得性肺炎？) ,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_双侧膝关节骨性关节病,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_肺部感染,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_成人Ph-急性淋巴细胞白血病,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_锁骨下盗血综合征伴锁骨下动脉狭窄(左侧) ,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_痛风性关节炎,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_手术后恶性肿瘤化学治疗,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_社区获得性肺炎,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_股骨骨折后遗症,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_结肠恶性肿瘤,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_细菌性肺炎,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_慢性肾脏病IV期 肾性贫血 高磷血症 继发性甲状旁腺功能亢进 代谢性酸中毒 血液透析 血管透析导管的机械性并发症,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_意识障碍(查因),分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_右侧髌骨骨折,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_慢性肾脏病V期 慢性心力衰竭 肾性贫血 低钙血症 高磷血症,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_呼吸困难,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_咯血,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_基底节出血(左侧) ,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_基底节出血(右侧基底节、丘脑、侧脑室旁白质) ,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_1,分类,1/25 (4.0%),3/63 (4.8%),1.0
主要疾病诊断_肾造瘘管移位,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_胫腓骨下端骨折(胫腓骨下端骨折术后),分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_胆囊结石伴有急性胆囊炎,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_脑梗死恢复期  偏瘫(左侧)  皮肤感觉减退(左侧)  肩关节半脱位(左),分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_腹腔占位性质待查,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_脑室腹腔分流管腹腔段外露,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_肾上腺肿物(左侧),分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_鞍区病变,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_-8,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_-4,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_-5,分类,0/25 (0.0%),1/63 (1.6%),1.0
VTE首次中高危评分日期与药物预防日期差值_-3,分类,1/25 (4.0%),1/63 (1.6%),1.0
主要疾病诊断_间变大细胞淋巴瘤,分类,0/25 (0.0%),1/63 (1.6%),1.0
主要疾病诊断_难治性心力衰竭,分类,0/25 (0.0%),1/63 (1.6%),1.0
